Injection of radiopaque hydrogel at time of lumpectomy improves the target definition for adjuvant radiotherapy

For localized cancers, breast-conserving therapy (BCT), including limited surgery and adjuvant whole breast radiotherapy, is equivalent to mastectomy in regard to oncologic outcomes while enabling breast preservation [1]. Oncoplastic techniques have been increasingly used worldwide to improve cosmesis [2 –4]. Those techniques involve, at minimum, a simple volume displacement (level 1 oncoplastic technique), as the breast parenchyma is approximated to close the lumpectomy cavity [5]. In so doing, the seroma is limited in size, and it often becomes invisible on a CT-scan.

Source: Radiotherapy and Oncology - December 15, 2018 Category: Radiology Authors: Gerson M. Struik, Nienke Hoekstra, Taco M. Klem, Ali Ghandi, Gerda M. Verduijn, Annemarie T. Swaak-Kragten, Alja Schoonbeek, Kim C. de Vries, Margriet A. Sattler, Kees Verhoef, Erwin Birnie, Jean-Philippe Pignol Tags: Original Article Source Type: research